Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) was $6.95 for the day, down -4.14% from the previous closing price of $7.25. In other words, the price has decreased by -$4.14 from its previous closing price. On the day, 0.77 million shares were traded.
Ratios:
Our analysis of DNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.88 and its Current Ratio is at 4.88. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 30 ’25 when Che Austin bought 99 shares for $7.12 per share.
Che Austin bought 99 shares of DNA for $754 on May 29 ’25. On May 28 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $6.96 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.71 while its Price-to-Book (P/B) ratio in mrq is 0.55.
Stock Price History:
Over the past 52 weeks, DNA has reached a high of $23.29, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is -3.76%, while the 200-Day Moving Average is calculated to be -19.38%.
Shares Statistics:
A total of 43.08M shares are outstanding, with a floating share count of 37.41M. Insiders hold about 32.63% of the company’s shares, while institutions hold 57.98% stake in the company.
